Loading...

Intra-Cellular Therapies, Inc.

ITCI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$131.87
$0.00(0.00%)

Intra-Cellular Therapies, Inc. (ITCI) Stock Chart & Performance Analysis

Explore Intra-Cellular Therapies, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.47%
3-Month Change
39.001%
6-Month Change
79.15%
Year-to-Date (YTD) Change
56.54%
1-Year Change
96.002%
3-Year Change
110.12%
5-Year Change
691.54%
All-Time (Max) Change
779.13%

Analyzing Intra-Cellular Therapies, Inc. (ITCI) Trends Across Multiple Time Frames

Intra-Cellular Therapies, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Intra-Cellular Therapies, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 0.47% rise could signal a pushback, whereas a 3-month rise of 39.001% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 79.15% and a YTD rise of 56.54% might concern investors, but a 1-year gain of 96.002% and a 3-year increase of 110.12% could indicate resilience. The 5-year surge of 691.54% highlights strong historical growth, while the all-time return of 779.13% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;